Skip to content

Clinical study of emblica spray on general anesthesia laparoscopic postoperative xerostomia

Clinical study of emblica spray on general anesthesia laparoscopic postoperative xerostomia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012113
Enrollment
Unknown
Registered
2017-07-24
Start date
2017-07-27
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative xerostomia

Interventions

experimental group:emblica spray
control group:Warm water spray

Sponsors

Guangdong Provincial of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. imaging diagnosis of gynecological benign tumors: such as uterine fibroids, ovarian cysts, teratoma, etc., and have indications of operation, laparoscopic surgery should be performed patients; 2. under general anesthesia, such as inhalation anesthesia and intravenous anesthesia; 3. routine use of atropine intramuscular injection, reduce intraoperative salivary gland and respiratory gland secretion; 4. aged 18-75 years; 5. the operation time was 1-3H, and it was the first laparoscopic patient on the day of operation; 6. informed consent, voluntary test. For patient informed consent, see research brief and informed consent bookmark page.

Exclusion criteria

Exclusion criteria: 1. suffering from dementia or severe mental illness, can not cope with experimental procedures and saliva flow tests and dry mouth symptoms assessment; 2. patients with severe systemic disease and unsuitable for experimental intervention, such as vascular, hepatic, renal, and hematopoietic diseases, have severe primary diseases; 3. of the patients had a history of diseases affecting the function of salivary glands and a history of medication within a month before surgery; 4. have a clear history of allergy of Phyllanthus emblica; 5. patients with oral diseases, such as periodontal disease.

Design outcomes

Primary

MeasureTime frame
Salivary flow rate;Tongue moistening oral mucosa;

Countries

China

Contacts

Public ContactHaixia He

Guangdong Provincial of Chinese Medicine

heidy08@163.com+86 13794360392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026